COVID-19 may spark diabetes in healthy individuals
Well-respected academics from around the world speculate that COVID-19 not just a risk for diabetic patients, but is also capable of triggering diabetes in healthy people. COVID-19 first erupted in Wuhan, China late last year. Since then scientists are still…
Dual attack: A synthetic peptide could work as a treatment and vaccine for COVID-19.
Ligandal has succeeded in applying its unique peptide-based technology to develop a synthetic peptide acting as both an antidote and a vaccine against COVID-19. With the whole world racing to find a treatment or vaccine against COVID-19, San Francisco based…
Is Dexamethasone an alternative in fight against COVID-19?
Dexamethasone low cost, anti-inflammatory steroid well known in the world of sports is the first drug to reduce death among COVID-19 patients. One of the common symptoms seen among COVID-19 patients is shortness of breath or respiratory failure. Recently, promising…
Advancements in serologic diagnostic tests could put an end to the COVID-19 test crisis
The University of Bologna along with Roche and Hitachi are working on making faster, cheaper diagnostic tests for COVID-19 with the help of electrochemiluminescence (ECL). Currently one of the main reasons for the rising number of COVID-19 cases is due…
No stones being unturned: Fluoxetine to disrupt viral replication in COVID-19 affected patients.
German experts speculate that Fluoxetine- an antidepressant drug can potentially reduce the viral replication in COVID-19 patients. Here’s more… The current COVID-19 pandemic has brought about unparalleled times for humanity. The measures taken to contain the virus have triggered a…
Biotech Industry Marking a New Era Post-COVID-19
The inevitable need for a COVID-19 treatment has stirred up much-needed interest in Biotech industries all over the world. Here a straightforward take on Biotech industries post-COVID-19. It is pretty astonishing how perceptions change in a short period of time….
